WallStreetZenWallStreetZen

NASDAQ: BNTC
Benitec Biopharma Inc Earnings & Revenue

BNTC past revenue growth

How has BNTC's revenue growth performed historically?
Company
-89.71%
Industry
83.77%
Market
19.55%
BNTC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BNTC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

BNTC earnings and revenue history

Current Revenue
$7.0k
Current Earnings
-$21.7M
Current Profit Margin
-309,885.7%

BNTC Return on Equity

Current Company
-175.4%
Current Industry
16.9%
Current Market
28.2%
BNTC's Return on Equity (-175.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BNTC announces earnings.

BNTC Return on Assets

Current Company
-127.8%
Current Industry
3.2%
BNTC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BNTC Return on Capital Employed

Current Company
-187.41%
Current Industry
-42.5%
BNTC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BNTC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BNTC$7.00k-$21.33M-$21.69M-88.01%N/A
TIL$0.00-$112.47M-$123.32M-100.00%N/A
ALRN$0.00-$17.93M-$18.07MN/AN/A
TPST$0.00-$26.24M-$29.76MN/AN/A
RLYB$0.00-$76.13M-$76.28MN/AN/A

Benitec Biopharma Earnings & Revenue FAQ

What were BNTC's earnings last quarter?

On Invalid Date, Benitec Biopharma (NASDAQ: BNTC) reported Q1 2024 earnings per share (EPS) of -$0.02, up 40.74% year over year. Total Benitec Biopharma earnings for the quarter were -$4.28 million. In the same quarter last year, Benitec Biopharma's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.

What was BNTC's earnings growth in the past year?

As of Q2 2024, Benitec Biopharma's earnings has grown year over year. Benitec Biopharma's earnings in the past year totalled -$21.69 million.

What was BNTC's revenue last quarter?

On Invalid Date, Benitec Biopharma (NASDAQ: BNTC) reported Q1 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Benitec Biopharma's revenue was $54.00 thousand.

What was BNTC's revenue growth in the past year?

As of Q2 2024, Benitec Biopharma's revenue has grown -89.71% year over year. This is 173.48 percentage points lower than the US Biotechnology industry revenue growth rate of 83.77%. Benitec Biopharma's revenue in the past year totalled $7.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.